What this guide covers
What external data the reports need
Under the EU MDR, Class I devices need a PMS report (Article 85) and Class IIa, IIb and III devices need a periodic safety update report, or PSUR (Article 86). The differences are covered in our PSUR vs PMS report guide. Both draw on the same kinds of outside information:
- Adverse events for your device and similar devices, from FDA MAUDE and other regulators.
- Recalls and field safety notices, yours and those for similar devices, in every market you sell into.
- Published literature, screened against defined criteria, with a reason recorded for every article you include or exclude.
- Clinical trials in your device category, especially ones that were stopped early.
- Trends: whether any of the above went up compared with the last period.
Why gathering it takes so long
Each source has its own website, search syntax and export format. Searches from last cycle have to be found and rerun with new dates. Counts have to be compared by hand with the previous report, which may have used slightly different searches. And when a notified body asks why a particular recall or article wasn't considered, the answer is often in someone's inbox, if it's anywhere.
For a PSUR due every year, this can take weeks. For a portfolio, it's a standing job.
The European Commission has proposed making Class IIb and III PSURs less frequent, every two years after the first. If that's adopted, there will be fewer reports, but each one will cover a longer period. Keeping the data current between reports matters more, not less, because there's more ground to cover when the report is due.
How MedFortis handles it
A data annex, on demand
MedFortis produces a data annex for your PMS report or PSUR that compares one period with the last for your devices, so you can see straight away what changed. You can run it whenever you need it, or schedule it weekly or monthly so the numbers are always current rather than assembled at the deadline.
Literature screening that keeps its reasons
A PubMed screening queue, based on the MEDDEV 2.7/1 rev 4 approach, lets your team include or exclude each article and record why. That record supports your duty under MDR Articles 83 and 84 to review external data, and it means the next report starts from where the last one finished.
Trials and trends in the same place
Terminated and suspended clinical trials in your device categories are shown first. Trend alerts flag when a device's reports rise above a threshold or above its own normal level, so a change shows up during the year, not when you sit down to write.
Drafts for a person to review
MedFortis can draft a compliance summary from the data. It's a starting point. A person reviews it, edits it and decides what goes into the report.
What it doesn't do
MedFortis doesn't write your PSUR, make your benefit-risk conclusion or replace your clinical evaluation. Sales volumes, complaint data and PMCF findings come from inside your business and stay in your QMS. It takes care of the external half of the work, the part that repeats every cycle, and keeps it up to date.
See the data behind your next report
Book a free 30-minute demo. We'll run MedFortis on your device lines and show you what an annex for them would contain.
Book a Demo →Key takeaways
- PMS reports (Class I) and PSURs (Class IIa, IIb, III) both need external data: adverse events, recalls, literature, trials and trends.
- Gathering it by hand each cycle is slow, inconsistent and hard to defend when questioned.
- MedFortis produces a period-on-period data annex on demand or on a schedule, screens literature with recorded reasons and flags trends during the year.
- Your team still writes the report and makes the benefit-risk call.